Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths. (2022)

• Record Type: Journal Article
• Authors: Qi, Yue; Liao, Kezhi; Liu, Tongyang; Zhang, Yu
• Is Part Of: Operations research perspectives. Volume 9(2022)
• Publication Date: 2022
• Subjects: Optimization -- Operational research algorithms -- Robust optimization -- Multiple-objective portfolio selection -- Counter-COVID measure -- Mean-parameterized nondominated path; Operations research -- Periodicals; Management science -- Periodicals; 658.403405
• DOI: 10.1016/j.orp.2022.100252
• Languages: English
• ISSNs: 2214-7160

Abstract

Abstract: The COVID-19 pandemic is unleashing crises of humanity, economy, and finance. Portfolio selection is widely recognized as the foundation of modern financial economics. Therefore, it is naturally crucial and inviting to utilize portfolio selection in order to counter COVID-19 in stock markets. We originate a counter-COVID measure for stocks, extend portfolio selection, and construct multiple-objective portfolio selection. Because of the uncertainty in measuring counter-COVID, we perform robust optimization. Specifically, we analytically compute the optimal solutions as a trail of an optimal portfolio due to the change of counter-COVID. We call the trail as mean-parameterized nondominated path . Moreover, the path is a continuous function of the change, so the portfolio relatively mildly varies for the change. In contrast, researchers typically still focus on 2-objective robust illustrations and infrequently explicitly compute the optimal solutions for multiple-objective portfolio optimization. To the best of our knowledge, there is limited research for multiple-objective portfolio selection of COVID and for the robust optimization of multiple-objective portfolio selection. In such an area, this paper contributes to the literature. The implications to fight COVID are that investors minimize risk, maximize return, and maximize counter-COVID in stock markets and that investors ascertain the multiple-objective portfolio selection as relatively robust. Highlights: It is crucial and inviting to utilize portfolio selection to counter COVID-19. We originate a counter-COVID measure for multiple-objective portfolio selection. We perform robust optimization for uncertainty in measuring counter-COVID. We analytically compute the optima as mean-parameterized nondominated path.